- 全部删除
- 您的购物车当前为空
Thalidomide-O-amido-PEG1-(C1-PEG)2-C2-NH2 is a synthesized conjugate compound known as an E3 ligase ligand-linker. It incorporates a cereblon ligand based on Thalidomide and a 3-unit PEG linker. This compound is specifically designed for use in PROTAC technology applications.
Thalidomide-O-amido-PEG1-(C1-PEG)2-C2-NH2 is a synthesized conjugate compound known as an E3 ligase ligand-linker. It incorporates a cereblon ligand based on Thalidomide and a 3-unit PEG linker. This compound is specifically designed for use in PROTAC technology applications.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
100 mg | 待询 | 待询 | |
500 mg | 待询 | 待询 |
Thalidomide-O-amido-PEG1-(C1-PEG)2-C2-NH2 相关产品
产品描述 | Thalidomide-O-amido-PEG1-(C1-PEG)2-C2-NH2 is a synthesized conjugate compound known as an E3 ligase ligand-linker. It incorporates a cereblon ligand based on Thalidomide and a 3-unit PEG linker. This compound is specifically designed for use in PROTAC technology applications. |
别名 | E3 Ligase Ligand-Linker Conjugates 23 TFA, Cereblon Ligand-Linker Conjugates 12 TFA |
分子量 | 648.58 |
分子式 | C27H35F3N4O11 |
密度 | no data available |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容